Immuneering Corp Company Insiders

Immuneering Corp Management Team Effectiveness

The company has return on total asset (ROA) of (0.579) % which means that it has lost $0.579 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0248) %, meaning that it created substantial loss on money invested by shareholders. Immuneering Corp's management efficiency ratios could be used to measure how well Immuneering Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -1.27 in 2025. Return On Capital Employed is likely to rise to -1.35 in 2025. At this time, Immuneering Corp's Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 1.4 M in 2025, whereas Net Tangible Assets are likely to drop slightly above 65.1 M in 2025. Common Stock Shares Outstanding is likely to drop to about 29.7 M in 2025. Net Loss is likely to rise to about (43.2 M) in 2025

Immuneering Corp Workforce Comparison

Immuneering Corp Insider Trading History

Immuneering Corp Notable Stakeholders

The success or failure of an entity such as Immuneering Corp often depends on how effective the management is. Immuneering Corp management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Immuneering management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Immuneering management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Immuneering Corp's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Immuneering Corp. Check Immuneering Corp's Beneish M Score to see the likelihood of Immuneering Corp's management manipulating its earnings.

When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.